NIAID Banner Logo Image

ONLINE DATABASE SEARCH HIV-LS-340-MEMO

1. 48365 HIV-LS-340; PUBMED-HIV-1/23/2006

Inhibitors of HIV-1 Protease by Using In Situ Click Chemistry

Whiting, M, Muldoon, J, Lin, YC, Silverman, SM, Lindstrom, W, Olson, AJ, Kolb, HC, Finn, MG, Sharpless, KB, Elder, JH, and Fokin, VV

Angew Chem Int Ed Engl 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16425339&dopt=abstract


2. 48366 HIV-LS-340; PUBMED-HIV-1/23/2006

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV

Gallant, JE, DeJesus, E, Arribas, JR, Pozniak, AL, Gazzard, B, Campo, RE, Lu, B, McColl, D, Chuck, S, Enejosa, J, Toole, JJ, and Cheng, AK

N Engl J Med 2006. 354(3): 251-60


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16421366&dopt=abstract


3. 48367 HIV-LS-340; PUBMED-HIV-1/23/2006

Structure-Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

Romines, KR, Freeman, GA, Schaller, LT, Cowan, JR, Gonzales, SS, Tidwell, JH, Andrews, CW 3rd, Stammers, DK, Hazen, RJ, Ferris, RG, Short, SA, Chan, JH, and Boone, LR

J Med Chem 2006. 49(2): 727-39


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16420058&dopt=abstract


4. 48368 HIV-LS-340; PUBMED-HIV-1/23/2006

HIV Integrase Inhibitors with Nucleobase Scaffolds: Discovery of a Highly Potent Anti-HIV Agent

Nair, V, Chi, G, Ptak, R, and Neamati, N

J Med Chem 2006. 49(2): 445-447


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16420027&dopt=abstract


5. 48369 HIV-LS-340; PUBMED-HIV-1/23/2006

Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by {alpha}-Hydroxytropolones

Semenova, EA, Johnson, AA, Marchand, C, Davis, DA, Yarchoan, R, and Pommier, Y

Mol Pharmacol 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16418335&dopt=abstract



6. 48370 HIV-LS-340; EMBASE-HIV-1/24/2006

Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor

Sevigny, G, Stranix, B, Tian, B, Dubois, A, Sauve, G, Petropoulos, C, Lie, Y, Hellmann, N, Conway, B, and Yelle, J

Antiviral Research 2006. In Press, Uncorrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T2H-4J32H1X-2/2/84a20ee29617b8c623aa20df7790046f


7. 48371 HIV-LS-340; PUBMED-HIV-1/23/2006

Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat

Yajima, S, Shionoya, H, Akagi, T, and Hamasaki, K

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16413787&dopt=abstract


8. 48372 HIV-LS-340; PUBMED-HIV-1/23/2006

Design, synthesis, and anti-integrase activity of catechol-DKA hybrids

Maurin, C, Bailly, F, Mbemba, G, Mouscadet, JF, and Cotelle, P

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16412645&dopt=abstract


9. 48373 HIV-LS-340; PUBMED-HIV-1/23/2006

Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides

Brzozowski, Z, Saczewski, F, and Neamati, N

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16406643&dopt=abstract


10. 48374 HIV-LS-340; PUBMED-HIV-1/23/2006

Anti-HIV-1 protease- and HIV-1 integrase activities of Thai medicinal plants known as Hua-Khao-Yen

Tewtrakul, S, Itharat, A, and Rattanasuwan, P

J Ethnopharmacol 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16406414&dopt=abstract



11. 48375 HIV-LS-340; PUBMED-HIV-1/23/2006

Anti-Tat and anti-HIV activities of trimers of n-alkylglycines

Marquez, N, Sancho, R, Macho, A, Moure, A, Masip, I, Messeguer, A, and Munoz, E

Biochem Pharmacol 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16405868&dopt=abstract


12. 48376 HIV-LS-340; PUBMED-HIV-1/23/2006

Structural Insights into the Mechanisms of Drug Resistance in HIV-1 Protease NL4-3

Heaslet, H, Kutilek, V, Morris, GM, Lin, YC, Elder, JH, Torbett, BE, and Stout, CD

J Mol Biol 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16403521&dopt=abstract


13. 48377 HIV-LS-340; EMBASE-HIV-1/24/2006

Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains

Smith III, Amos B, Charnley, Adam K, Harada, Hironori, Beiger, Jason J, Cantin, Louis-David, Kenesky, Craig S, Hirschmann, Ralph, Munshi, Sanjeev, Olsen, David B, and Stahlhut, Mark W

Bioorganic & Medicinal Chemistry Letters 2006. 16(4): 859-863


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF9-4HKMPP6-5/2/fde2a4c769b5d49d0744245042179c3a


14. 48378 HIV-LS-340; PUBMED-HIV-1/23/2006

Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties

Sriram, D, Bal, TR, and Yogeeswari, P

J Pharm Pharm Sci 2005. 8(3): 565-77


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16401403&dopt=abstract


15. 48379 HIV-LS-340; PUBMED-HIV-1/23/2006

Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices

Dong, J and Xiong, H

J Neurosci Res 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16400660&dopt=abstract



16. 48380 HIV-LS-340; EMBASE-HIV-1/24/2006

Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-[kappa]B inactivation

Moriuchi, Masako, Yoshimine, Hiroyuki, Oishi, Kazunori, and Moriuchi, Hiroyuki

Virology 2006. 345(1): 167-173


HYPERLINK:

http://www.sciencedirect.com/science/article/B6WXR-4HGM73D-3/2/9e133a28b35343316263be16e4bb9875


17. 48381 HIV-LS-340; EMBASE-HIV-1/24/2006

Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Ruiz-Caro, Juliana, Basavapathruni, Aravind, Kim, Joseph T, Bailey, Christopher M, Wang, Ligong, Anderson, Karen S, Hamilton, Andrew D, and Jorgensen, William L

Bioorganic & Medicinal Chemistry Letters 2006. 16(3): 668-671


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF9-4HKCYSV-1/2/ce87db516a8490685f5de13f308064a7


18. 48382 HIV-LS-340; PUBMED-HIV-1/23/2006

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients

Gianotti, N, Galli, L, Boeri, E, Maillard, M, Serra, G, Ratti, D, Gallotta, G, Vacchini, D, Tremolada, Y, Lazzarin, A, Clementi, M, and Castagna, A

New Microbiol 2005. 28(4): 319-26


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16386016&dopt=abstract


19. 48383 HIV-LS-340; PUBMED-HIV-1/23/2006

R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors

Gondois-Rey, F, Biancotto, A, Fernandez, MA, Bettendroffer, L, Blazkova, J, Trejbalova, K, Pion, M, and Hirsch, I

J Virol 2006. 80(2): 854-65


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16378987&dopt=abstract


20. 48384 HIV-LS-340; PUBMED-HIV-1/23/2006

Discovery of Next Generation Inhibitors of HIV Protease

Spaltenstein, A, Kazmierski, WM, Miller, JF, and Samano, V

Curr Top Med Chem 2005. 5(16): 1589-607


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16375744&dopt=abstract



21. 48385 HIV-LS-340; EMBASE-HIV-1/24/2006

Conformationally restrained carbazolone-containing [alpha],[gamma]-diketo acids as inhibitors of HIV integrase

Li, Xingnan and Vince, Robert

Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4HYMW0Y-1/2/6bb52e518d534eb3fdb08a5f8ca2b7b6


22. 48386 HIV-LS-340; EMBASE-HIV-1/24/2006

Bleomycin has antiviral properties against drug-resistant HIV strains and sensitises virus to currently used antiviral agents

Georgiou, Niki A, van der Bruggen, Tjomme, Healy, Derek MC, van Tienen, Carla, de Bie, Prim, Oudshoorn, Maroeska, Marx, Joannes JM, and van Asbeck, BSweder

International Journal of Antimicrobial Agents 2006. 27(1): 63-68


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T7H-4HR75KH-1/2/189ef187d2c7118ab04b119ddcba35aa


23. 48387 HIV-LS-340; EMBASE-HIV-1/24/2006

Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks

Fernandez, Michael and Caballero, Julio

Bioorganic & Medicinal Chemistry 2006. 14(1): 280-294


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4H7T0J0-3/2/4614f155a6b59734916ea15c034c0d34


24. 48388 HIV-LS-340; WOS-HIV-1/15/2006

Synthetic approaches to nuclease-resistant, nonnatural dinucleotides of anti-HIV integrase interest

Chi, GC and Nair, V

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2005. 24(10-12): 1449-1468, 20


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234060900005


25. 48389 HIV-LS-340; WOS-HIV-1/15/2006

Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8

Haskell, CA, Horuk, R, Liang, M, Rosser, M, Dunning, L, Islam, I, Kremer, L, Gutierrez, J, Marquez, G, Martinez, C, Biscone, MJ, Doms, RW, and Ribeiro, S

MOLECULAR PHARMACOLOGY 2006. 69(1): 309-316, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234252000032


26. 48390 HIV-LS-340; WOS-HIV-1/15/2006

Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1

Morris, KV and Looney, DJ

HUMAN GENE THERAPY 2005. 16(12): 1463-1472, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234253000011



27. 48391 HIV-LS-340; WOS-HIV-1/15/2006

Human immunodeficiency virus (HIV) entry inhibitors (CCR5 specific blockers) in development: Are they the next novel therapies?

Idemyor, V

HIV CLINICAL TRIALS 2005. 6(5): 272-277, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234165600005


28. 48392 HIV-LS-340; WOS-HIV-1/15/2006

Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal

Zhang, JZ, Liu, Y, Henao, J, Rugeles, MT, Li, JL, Chen, T, and He, JJ

GENE 2005. 363: 67-76, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234166700008


29. 48393 HIV-LS-340; WOS-HIV-1/15/2006

Second-generation cycloSal-d4TMP pronucleotides bearing esterase-cleavable sites - the "trapping" concept

Meier, C, Ducho, C, Jessen, H, Vukadinovic-Tenter, D, and Balzarini, J

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 2005.(1): 197-206, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234237500019


30. 48394 HIV-LS-340; WOS-HIV-1/22/2006

Phenolics with anti-HSV and anti-HIV activities from Artocarpus gomezianus , Mallotus pallidus , and Triphasia trifolia

Likhitwitayawuid, K, Supudompol, B, Sritularak, B, Lipipun, V, Rapp, K, and Schinazi, RF

PHARMACEUTICAL BIOLOGY 2005. 43(8): 651-657, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234398600002


31. 48395 HIV-LS-340; WOS-HIV-1/22/2006

Simple synthesis and anti-HIV activity of novel cyclopentene phosphonate nucleosides

Kim, A and Hong, JH

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 1-8, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200001


32. 48396 HIV-LS-340; WOS-HIV-1/22/2006

New AZT conjugates as potent anti-HIV agents

You, ZQ and Lee, HJ

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 37-54, 18


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200005


33. 48397 HIV-LS-340; WOS-HIV-1/22/2006

Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine

Feng, JY, Myrick, FT, Margot, NA, Mulamba, GB, Rimsky, L, Borroto-Esoda, K, Selmi, B, and Canard, B

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 89-107, 19


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200009


34. 48398 HIV-LS-340; WOS-HIV-1/22/2006

Synthesis and antiviral evaluation of novel 4 '-hydroxymethyl branched apiosyl nucleosides

Kim, JW and Hong, JH

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 109-117, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200010


35. 48399 HIV-LS-340; WOS-HIV-1/22/2006

CCR5 Delta 32, CCR2-64I, and SDF1-3 ' A polymorphisms related to resistance to HIV-1 infection and disease in the Ecuadorian population

Paz-y-Mino, C, Morillo, SA, Celi, AP, Witte, T, Guijarro, MJM, Collantes, JC, and Leone, PE

HUMAN BIOLOGY 2005. 77(4): 521-526, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234289000010


36. 48400 HIV-LS-340; WOS-HIV-1/22/2006

Tipranavir: a protease inhibitor for multi-drug resistant HIV-1

Best, B and Haubrich, R

EXPERT OPINION ON INVESTIGATIONAL DRUGS 2006. 15(1): 59-70, 12


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234421000006


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021